Ocugen, Inc. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 10th, 2022 • Ocugen, Inc. • Biological products, (no disgnostic substances) • New York
Ocugen, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., LLC, Roth Capital Partners, LLC and Chardan Capital Markets, LLC (each, an “Agent” and together, the “Agents”), as follows:
